Market Research Report
Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026
|Published by||Black Swan Analysis||Product code||339840|
|Published||Content info||58 Pages
Delivery time: 1-2 business days
|Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026|
|Published: August 1, 2016||Content info: 58 Pages||
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Dry Eye Syndrome in 14 Major Markets
Dry Eye Syndrome (DES), also known as Keratoconjunctivitis sicca, is a multi-factorial disorder of the tear film which occurs due to a tear deficiency or excessive tear evaporation. Dry Eye Syndrome is categorized by inflammation of the ocular surface and the lachrymal glands. Patients will often report ocular discomfort as well as the inclusion of a variety of symptoms such as excessive tearing and blurred vision.
This report provides the current prevalent population for Dry Eye Syndrome across 14 Major Markets (USA, France, Germany, Italy, Spain, UK, Japan, China, India, Brazil, Mexico, Australia, Canada and S.Korea) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Dry Eye Syndrome have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Dry Eye Syndrome include:
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.